Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukio Maezawa

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case in Which Acotiamide Hydrochloride Was Effective for Reflux Esophagitis after Distal Gastrectomy with Billroth Ⅰ Reconstruction for Gastric Cancer]Yukio Maezawa, Toru Aoyama, Junya Morita, et al.
Journal of Cancer|October 22, 2019
Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancerYukio Maezawa, Toru Aoyama, Kazuki Kano, et al.
Anticancer Research|April 30, 2022
Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective StudyKeisuke Komori, Kazuki Kano, Takanobu Yamada, et al.
Langenbeck'S Archives of Surgery|October 21, 2024
Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Anticancer Research|May 31, 2024
Comparison of Survival Between ypStage and pStage in Gastric CancerKeisuke Komori, Takanobu Yamada, Shuji Ando, et al.
In Vivo (Athens, Greece)|April 28, 2022
Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Daisuke Machida, et al.
In Vivo (Athens, Greece)|March 1, 2020
Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal CancerToru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
In Vivo (Athens, Greece)|June 27, 2025
The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After EsophagectomyToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 2, 2018
[A Case of Long-Term Survival with Multidisciplinary Treatment in Unresectable Advanced Gastric Cancer Found with Ovarian Tumor]Suguru Nukada, Toru Aoyama, Mariko Kamiya, et al.
BMC Cancer|November 28, 2024
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resectionShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case in Which Acotiamide Hydrochloride Was Effective for Reflux Esophagitis after Distal Gastrectomy with Billroth Ⅰ Reconstruction for Gastric Cancer]Yukio Maezawa, Toru Aoyama, Junya Morita, et al.
Journal of Cancer|October 22, 2019
Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancerYukio Maezawa, Toru Aoyama, Kazuki Kano, et al.
Anticancer Research|April 30, 2022
Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective StudyKeisuke Komori, Kazuki Kano, Takanobu Yamada, et al.
Langenbeck'S Archives of Surgery|October 21, 2024
Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Anticancer Research|May 31, 2024
Comparison of Survival Between ypStage and pStage in Gastric CancerKeisuke Komori, Takanobu Yamada, Shuji Ando, et al.
In Vivo (Athens, Greece)|April 28, 2022
Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Daisuke Machida, et al.
In Vivo (Athens, Greece)|March 1, 2020
Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal CancerToru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
In Vivo (Athens, Greece)|June 27, 2025
The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After EsophagectomyToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 2, 2018
[A Case of Long-Term Survival with Multidisciplinary Treatment in Unresectable Advanced Gastric Cancer Found with Ovarian Tumor]Suguru Nukada, Toru Aoyama, Mariko Kamiya, et al.
BMC Cancer|November 28, 2024
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resectionShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Pageof 17